AJP - Heart and Circulatory Physiology, Vol 272, Issue 4 1810-H1818, Copyright © 1997 by American Physiological Society

ARTICLES

Cell cycle effects of nitric oxide on vascular smooth muscle cells

R. Sarkar, D. Gordon, J. C. Stanley and R. C. Webb
Department of Physiology, University of Michigan Medical Center, Ann Arbor 48109, USA.

We characterized the cell cycle block induced by nitric oxide (NO) on smooth muscle cells (SMC). We hypothesized that the inhibition of SMC proliferation by NO was due to a specific block in cell cycle progression. Treatment of cultured rat aortic SMC with the NO donors S-nitroso-N-acetylpenicillamine or S-nitrosoglutathione (0.1 mM for 48 h) resulted in a 50% decrease (P < 0.05) in the fraction of cells in the S and G2 + M phases and a corresponding increase in the G1 fraction, suggesting that NO inhibits entry into S phase, causing accumulation of cells in G1 phase. Application of both NO donors to cycling SMC resulted in a short-term, concentration-dependent (0.06-0.3 mM) inhibition of ongoing DNA synthesis as measured by radiothymidine incorporation, demonstrating that NO causes an S-phase arrest. The S-phase arrest by NO was not mimicked by exogenous guanosine 3',5'-cyclic monophosphate (cGMP, 10 mM) and was associated with, but not due to, a 20% inhibition of RNA synthesis. The S-phase block was completely reversed within 2 h of removal of the NO donors, similar to inhibition by the ribonucleotide reductase inhibitor hydroxyurea. Prolonged treatment of SMC with either NO donor (0.1 mM) did not synchronize cells at the G1-S boundary as expected after a prolonged S-phase arrest, but instead induced a quiescent G0-like state characterized by a 12- to 18-h lag before DNA synthesis returned to normal levels after NO removal. These findings demonstrate that NO inhibition of SMC proliferation is associated with two distinct and reversible cell cycle arrests, an immediate cGMP-independent S-phase block followed by a shift back in the cell cycle from the G1-S boundary to a quiescent G0-like state.

This article has been cited by other articles:

				A. N. Lyle and K. K. Griendling Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology, August 1, 2006; 21: 269 - 280. [Abstract] [Full Text] [PDF]

				Y. Nakamura, Y. Yamagata, N. Sugino, H. Takayama, and H. Kato Nitric Oxide Inhibits Oocyte Meiotic Maturation Biol Reprod, November 1, 2002; 67(5): 1588 - 1592. [Abstract] [Full Text] [PDF]

				F. Yang, A. von Knethen, and B. Brüne Modulation of nitric oxide-evoked apoptosis by the p53-downstream target p21WAF1/CIP1 J. Leukoc. Biol., December 1, 2000; 68(6): 916 - 922. [Abstract] [Full Text]

				F. C. Tanner, P. Meier, H. Greutert, C. Champion, E. G. Nabel, and T. F. Luscher Nitric Oxide Modulates Expression of Cell Cycle Regulatory Proteins : A Cytostatic Strategy for Inhibition of Human Vascular Smooth Muscle Cell Proliferation Circulation, April 25, 2000; 101(16): 1982 - 1989. [Abstract] [Full Text] [PDF]

				M. Ishigami, D. K. Swertfeger, M. S. Hui, N. A. Granholm, and D. Y. Hui Apolipoprotein E Inhibition of Vascular Smooth Muscle Cell Proliferation but Not the Inhibition of Migration Is Mediated Through Activation of Inducible Nitric Oxide Synthase Arterioscler. Thromb. Vasc. Biol., April 1, 2000; 20(4): 1020 - 1026. [Abstract] [Full Text] [PDF]

				M. Gu and P. Brecher Nitric Oxide-Induced Increase in p21Sdi1/Cip1/Waf1 Expression During the Cell Cycle in Aortic Adventitial Fibroblasts Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 27 - 34. [Abstract] [Full Text] [PDF]

				A. M. Hamad, S. R. Johnson, and A. J. Knox Antiproliferative effects of NO and ANP in cultured human airway smooth muscle Am J Physiol Lung Cell Mol Physiol, November 1, 1999; 277(5): L910 - L918. [Abstract] [Full Text] [PDF]

				R. Bundy, N. Marczin, A. H. Chester, and M. Yacoub Differential regulation of DNA synthesis by nitric oxide and hydroxyurea in vascular smooth muscle cells Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1799 - H1807. [Abstract] [Full Text] [PDF]

				B. Hocher, I. George, J. Rebstock, A. Bauch, A. Schwarz, H.-H. Neumayer, and C. Bauer Endothelin System–Dependent Cardiac Remodeling in Renovascular Hypertension Hypertension, March 1, 1999; 33(3): 816 - 822. [Abstract] [Full Text] [PDF]

				J.-D. Chiche, S. M. Schlutsmeyer, D. B. Bloch, S. M. de la Monte, J. D. Roberts Jr., G. Filippov, S. P. Janssens, A. Rosenzweig, and K. D. Bloch Adenovirus-mediated Gene Transfer of cGMP-dependent Protein Kinase Increases the Sensitivity of Cultured Vascular Smooth Muscle Cells to the Antiproliferative and Pro-apoptotic Effects of Nitric Oxide/cGMP J. Biol. Chem., December 18, 1998; 273(51): 34263 - 34271. [Abstract] [Full Text] [PDF]

				Y. M. W. Janssen, R. Soultanakis, K. Steece, E. Heerdt, R. J. Singh, J. Joseph, and B. Kalyanaraman Depletion of nitric oxide causes cell cycle alterations, apoptosis, and oxidative stress in pulmonary cells Am J Physiol Lung Cell Mol Physiol, December 1, 1998; 275(6): L1100 - L1109. [Abstract] [Full Text] [PDF]

				R. C. Braun-Dullaeus, M. J. Mann, and V. J. Dzau Cell Cycle Progression : New Therapeutic Target for Vascular Proliferative Disease Circulation, July 7, 1998; 98(1): 82 - 89. [Abstract] [Full Text] [PDF]

				K. Guo, V. Andres, and K. Walsh Nitric Oxide–Induced Downregulation of Cdk2 Activity and Cyclin A Gene Transcription in Vascular Smooth Muscle Cells Circulation, May 26, 1998; 97(20): 2066 - 2072. [Abstract] [Full Text] [PDF]

				S. Mohr, T. S. McCormick, and E. G. Lapetina Macrophages resistant to endogenously generated nitric oxide-mediated apoptosis are hypersensitive to exogenously added nitric oxide donors: Dichotomous apoptotic response independent of caspase 3 and reversal by the mitogen-activated protein kinase kinase (MEK) inhibitor PD 098059 PNAS, April 28, 1998; 95(9): 5045 - 5050. [Abstract] [Full Text] [PDF]

				L. L. Couper, S. R. Bryant, J. Eldrup-Jorgensen, C. E. Bredenberg, and V. Lindner Vascular Endothelial Growth Factor Increases the Mitogenic Response to Fibroblast Growth Factor-2 in Vascular Smooth Muscle Cells In Vivo via Expression of fms-Like Tyrosine Kinase-1 Circ. Res., December 19, 1997; 81(6): 932 - 939. [Abstract] [Full Text]